Investigation on the clinical efficacy and mechanism of compound kushen injection in treating esophageal cancer based on multi-dimensional network meta-analysis and in vitro experiment

被引:10
作者
Zhou, Wei [1 ]
Huang, Zhihong [1 ]
Wu, Chao [1 ]
Lu, Shan [1 ]
Fu, Changgeng [2 ]
Ye, Peizhi [3 ,4 ]
Tan, Yingying [1 ]
Wu, Zhishan [1 ]
Fan, Xiaotian [1 ]
Zhang, Jingyuan [1 ]
Guo, Siyu [1 ]
Jia, Shanshan [1 ]
Stalin, Antony [5 ]
Wang, Haojia [1 ]
Zhang, Xiaomeng [1 ]
Wang, Miaomiao [1 ]
Wu, Jiarui [1 ]
机构
[1] Beijing Univ Chinese Med, Beijing 100102, Peoples R China
[2] China Acad Chinese Med Sci, Xiyuan Hosp, Beijing 100091, Peoples R China
[3] Chinese Acad Med Sci, Canc Hosp, Natl Canc Ctr, Natl Clin Res Ctr Canc,Chinese Med Dept, Beijing 100021, Peoples R China
[4] Peking Union Med Coll, Beijing 100021, Peoples R China
[5] Zhejiang A&F Univ, Dept Tradit Chinese Med, State Key Lab Subtrop Silviculture, Hangzhou 311300, Peoples R China
关键词
Esophageal cancer; Network meta-analysis; Clinical efficacy; Compound kushen injection; Mechanism; In vitro experiment; GROWTH-FACTOR RECEPTOR; AURORA-A; EGFR; OVEREXPRESSION; TARGETS;
D O I
10.1016/j.jep.2021.114386
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Ethnopharmacological relevance: Esophageal cancer, as a high incidence of gastrointestinal cancer, has an indelible impact on human life and health. The combination of Chinese herbal injections and chemotherapy is commonly applied in the treatment of Esophageal cancer. Aim of the study: This study aimed to confirm the clinical advantage of Compound Kushen Injection to treat esophageal cancer and explore its molecular mechanism. Methods: The network meta-analysis method was used for the clinical evaluation of anti-tumor Chinese herbal injections. Initially, several electronic databases were searched to identify randomized controlled trials regarding Chinese herbal injections to treat esophageal cancer from their inception to September 5, 2020. Then, WinBugs and Stata software was used to calculate and analyze the outcome indicators, including total clinical efficiency, improvement of quality of life and adverse reactions. Furthermore, the surface under the cumulative ranking curve and three-dimensional cluster analysis were used to rank the efficacy and safety of Chinese herbal injections about each outcome. Cell Counting Kit-8 assay was used to observe the effect of Compound Kushen Injection on the proliferation of esophageal cancer cells. Real-Time Quantitative PCR and Western Blot analysis were used to detect the mRNA and protein expression of EGFR and AURKA in ESCA cells. Results: The surface under the cumulative ranking curve of Compound Kushen Injection combined with chemotherapy in total clinical efficiency, quality of life, reduction of nausea and vomiting were ranking at 89.1%, 81.8% and 92.4%, respectively. Compound Kushen Injection was determined as the dominant variety in the treatment of esophageal cancer which can inhibit the proliferation of esophageal cancer cells and down regulate the overexpression of EGFR and AURKA mRNA and protein. Conclusion: In this study, network meta-analysis was applied to confirm that Compound Kushen Injection has a curative effect on esophageal cancer and is superior to other anti-tumor Chinese herbal injections. Combined with the network pharmacology and in vitro experiment, the mechanism of Compound Kushen Injection inhibiting the proliferation of esophageal cancer cells by regulating the abnormal expression of EGFR and AURKA was revealed.
引用
收藏
页数:16
相关论文
共 116 条
[1]   Epidermal growth factor receptor (EGFR) is an independent adverse prognostic factor in esophageal adenocarcinoma patients treated with cisplatin-based neoadjuvant chemotherapy [J].
Aichler, Michaela ;
Motschmann, Martin ;
Juetting, Uta ;
Luber, Birgit ;
Becker, Karen ;
Ott, Katja ;
Lordick, Florian ;
Langer, Rupert ;
Feith, Marcus ;
Siewert, Joerg Ruediger ;
Walch, Axel .
ONCOTARGET, 2014, 5 (16) :6620-6632
[2]  
郑慧禹, 2012, [中国中医药信息杂志, Chinese Journal of Information on Traditional Chinese Medicine], V19, P85
[3]  
[Anonymous], 2014, ANTITUMOR PHARM, DOI [DOI 10.3969/J.ISSN.2095-1264.2014.013, 10.3969/j.issn.2095-1264.2014.013]
[4]  
[Anonymous], 2013, CANC RES CLIN
[5]  
[Anonymous], 2011, CLIN J CHINESE MED
[6]  
[Anonymous], 2013, GUANGXI MED J
[7]  
[Anonymous], 2009, INNER MONGOLIA MED J
[8]  
[Anonymous], 2011, CHINESE J EXPT TRADI, DOI [DOI 10.13422/J.CNKI.SYFJX.2011.05.084, 10.13422/j.cnki.syfjx.2011.05.084]
[9]  
Balshaguri<bullet>Zabihuula Mukhdes Ilias, 2020, CHINA MED HERALD, V17, P106
[10]   Aurora-A: the maker and breaker of spindle poles [J].
Barr, Alexis R. ;
Gergely, Fanni .
JOURNAL OF CELL SCIENCE, 2007, 120 (17) :2987-2996